The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.

Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...

After 1 year of biologic therapy, admissions requiring noninvasive ventilation among patients with COPD and type 2 ...

Respiratory diseases such as Asthma and Chronic Obstructive Pulmonary Disease (COPD) are on the rise partly because of ...

The Chronic Obstructive Pulmonary Disease Pipeline report embraces in-depth commercial and clinical assessment of the ...

A clean indoor environment can help reduce exposure to pollution. “Use an air purifier with a HEPA filter and seal windows ...

If you start to experience symptoms like chest pain, blue lips, or coughing up more than a teaspoon of blood, you should see ...

Respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and lung cancer, ...

Previous non-experimental studies suggest an association between paracetamol exposure in the first year of life and subsequent asthma and eczema developing in childhood; however, randomised trials are ...

Abstract: Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading cause of death worldwide and is often accompanied by comorbidities. Patients, due to their health condition, may experience ...

Women face a higher risk of lung damage compared to men, even if they have never smoked. Research shows that biological differences and smaller lung capacity make women more vulnerable to respiratory ...